Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Exponent, Inc. (EXPO) SEC Filings & Earnings Calls

EquiReason read 10 Exponent, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Exponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization..

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

EXPOExponent, Inc.Follow EXPO — free
Engineering & Construction · Industrials
—
Price chart with a free account
Market cap
3.7B
P/E TTM
34.7
Dividend yield
1.6%
52-week
—
Next earnings
29 Oct, in 5 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

7 Aug 202610-QExponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization.earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q2-2026$172M+21% y/y
Net income · Q2-2026$29M+11% y/y
Diluted EPS · Q2-2026$0.60+15% y/y
Billable hours · Q2-2026390,000+9% y/y
Utilization · Q2-202674.0%
Average technical FTE employees · Q2-20261,012+6% y/y
EBITDA · Q2-2026$43M+16% y/y

Risks flagged

Concentration risk from large project

“This work includes a large study that represented approximately 4% of our net revenues during the quarter.” · word for word

Dependence on AI-related demand sustainability

“Our proactive work experienced strong growth in the quarter, led by demand for user research studies as clients accelerate the development of AI-enabled products.” · word for word
Read the original on SEC EDGAR ↗
30 Jul 20268-K · 2.02, 7.01Exponent reported Q2 2026 revenue growth of 21% to $171.6M, net income up to $29.4M from $26.6M, and raised FY2026 guidance for revenue growth to 9%-10% and EBITDA margin to 27.8%-28.1%. Also declared $0.31 dividend and authorized $50M buybearningsopen

Figures in the filing · each found in the filing text

Total revenues · Q2-2026$172M+21% y/y
Revenues before reimbursements · Q2-2026$149M+12% y/y
Net income · Q2-2026$29M+11% y/y
Earnings per share, diluted · Q2-2026$0.60+15% y/y
EBITDA · Q2-2026$43M+15% y/y
EBITDA margin · Q2-202628.7%
Consolidated tax rate · Q2-202627.9%
Utilization · Q2-202674.0%
Cash and cash equivalents · Q2-2026$67M
Dividends paid · H1-2026$31M

Guidance

FY2026 revenues before reimbursements growth raised to 9%-10% from prior; FY2026 EBITDA margin raised to 27.8%-28.1% from prior; Q3 revenues before reimbursements growth 8%-10%; Q3 EBITDA margin 28.0%-28.5%

Raised FY2026 guidance for revenue growth and EBITDA margin, reflecting strong demand and disciplined execution.

Risks flagged

No specific new risks identified; standard forward-looking statements.

“Factors that could cause material differences include demand decline, timing of engagements, competitive services, absence of backlog, ability to retain key employees, tort reform, and government regulation.”
Read the original on SEC EDGAR ↗
8 May 202610-QRevenue $166M (+14% y/y); Net Income $30M (+11% y/y); Billable Hours 399,000 (+6% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$166M+14% y/y
Net Income · Q1-2026$30M+11% y/y
Billable Hours · Q1-2026399,000+6% y/y
Utilization · Q1-202676.0%
Technical FTE Employees · Q1-20261,013+5% y/y
EBITDA · Q1-2026$43M+15% y/y
EBITDA Margin · Q1-202628.4%
Engineering & Other Scientific Revenue · Engineering and Other Scientific · Q1-2026$141M+16% y/y
Environmental & Health Revenue · Environmental and Health · Q1-2026$25M+7% y/y
Diluted EPS · Q1-2026$0.59+14% y/y

Risks flagged

Deferred compensation volatility

“The increase in corporate operating expenses was due to the change in value of assets associated with our deferred compensation plan.” · word for word

Interest income decline

“During the first quarter of 2026 interest income decreased by $996,000 due to a decrease in interest rates and lower average cash equivalent balances.” · word for word
Read the original on SEC EDGAR ↗
30 Apr 20268-K · 2.02, 7.01Total revenues $166M (+14% y/y); Net income $30M (+11% y/y); EBITDA $43M (+15% y/y); Guidance: High-single-digit revenue growth for FY2026earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q1-2026$166M+14% y/y
Net income · Q1-2026$30M+11% y/y
EBITDA · Q1-2026$43M+15% y/y
Diluted EPS · Q1-2026$0.59+14% y/y
Utilization · Q1-202676.0%

Guidance

High-single-digit revenue growth for FY2026

Guidance reaffirmed: high-single-digit revenue growth, EBITDA margin 27.6%-28.1% for FY2026

Read the original on SEC EDGAR ↗
20 Apr 2026DEF 14AProxy statement filed for shareholder vote; no material event.open

Figures in the filing · each found in the filing text

Net income · FY2025$106M
EBITDA · FY2025$148M
Total Shareholder Return · FY2025$82.00
Employee bonus pool · FY2025$77M
Read the original on SEC EDGAR ↗
6 Apr 20268-K · 5.02President base salary $650,000.00; CFO base salary $525,000.00; President stock options 21,000open

Figures in the filing · each found in the filing text

President base salary$650000.00
CFO base salary$525000.00
President stock options21,000
CFO stock options12,600

Risks flagged

Leadership transition risk; new President and CFO taking over, though both are internal promotions.

“Appointment of new President and CFO effective May 1, 2026. Both are internal candidates with long tenure.”

Board retirement of Chairman may reduce institutional knowledge.

“Paul R. Johnston retiring from Board effective June 4, 2026. Karen Richardson to become Chairman.”
Read the original on SEC EDGAR ↗
27 Feb 202610-KTechnical full-time equivalent employees 973 (+1% y/y); Total employees 1,212; Employees with advanced degrees 922open

Figures in the filing · each found in the filing text

Technical full-time equivalent employees · FY2025973+1% y/y
Total employees · 2026-01-021,212
Employees with advanced degrees · 2026-01-02922
Employees with doctorate degrees · 2026-01-02731
Revenue concentration - consumer products · FY202521.0%
Revenue concentration - energy and utilities · FY202520.0%
Revenue concentration - transportation · FY202516.0%
Revenue concentration - chemical · FY202511.0%
Standard billing rate - low · FY2025$225.00
Standard billing rate - high · FY2025$1375.00

Risks flagged

Competitive Pricing Pressure

“Although we believe that we generally compete favorably in each of these areas, some of our competitors may be able to provide services acceptable to our clients at lower prices.” · word for word

Low Barriers to Entry

“We believe that the barriers to entry are low and that for many of our technical disciplines, competition is increasing.” · word for word

Dependence on Key Personnel

“Our success depends, to a significant degree, on our ability to attract and retain highly-skilled and qualified personnel, as well as the continued contributions of those individuals.”

Litigation and Liability Risk

“We face risks of loss resulting from, but not limited to, errors relating to transaction processing and technology, breaches of our internal control system or external compliance requirements, fraud or unauthorized transactions by employees or third parties, cybersecurity incidents, ineffective business continuation and disaster recovery activities.”
Read the original on SEC EDGAR ↗
5 Feb 20268-K · 2.02, 7.01Total revenues $147M (+8% y/y); Revenues before reimbursements $129M (+4% y/y); Net income $25M (+5% y/y); Guidance: FY2026 revenue growth high-single digits; EBITDA margin 27.6%-28.1%earningsopen

Figures in the filing · each found in the filing text

Total revenues · Q4-2025$147M+8% y/y
Revenues before reimbursements · Q4-2025$129M+5% y/y
Net income · Q4-2025$25M+5% y/y
EBITDA · Q4-2025$35M+11% y/y
EBITDA margin · Q4-202526.8%
Total revenues · FY2025$582M+4% y/y
Net income · FY2025$106M-3% y/y
EBITDA · FY2025$148M+1% y/y
EPS diluted · Q4-2025$0.49+7% y/y
EPS diluted · FY2025$2.07-2% y/y

Guidance

FY2026 revenue growth high-single digits; EBITDA margin 27.6%-28.1%

Guidance for high-single digit revenue growth in FY2026; EBITDA margin expected to expand to 27.6%-28.1%.

Read the original on SEC EDGAR ↗
7 Nov 202510-QExponent reported Q3 2025 results with 8% revenue growth, 8% net income growth, and announced a new $100M buyback authorization.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$147M+8% y/y
Net income · Q3-2025$28M+8% y/y
Diluted EPS · Q3-2025$0.55+10% y/y
EBITDA · Q3-2025$39M+9% y/y
Utilization · Q3-202574.0%
Technical full-time equivalent employees · Q3-2025976+3% y/y
Engineering & Other Scientific Revenue · Engineering & Other Scientific · Q3-2025$124M+8% y/y
Environmental & Health Revenue · Environmental & Health · Q3-2025$23M+10% y/y
Operating Cash Flow · 9M-2025$76M-14% y/y
Free Cash Flow · 9M-2025$69M-18% y/y

Risks flagged

Dependence on key employees and talent retention

“We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.” · word for word

Lease obligation risk

“On June 19, 2024, we entered into an agreement with the State of Arizona to extend our land lease for 15 years beginning on January 17, 2028... Beginning on January 17, 2028, our payments under the lease will increase to approximately $6,183,000 per year for the 15-year extension term.” · word for word
Read the original on SEC EDGAR ↗
30 Oct 20258-K · 2.02, 7.01Total revenues $147M (+8% y/y); Revenues before reimbursements $137M (+10% y/y); Net income $28M (+8% y/y); Guidance: Raising margin guidanceearningsopen

Figures in the filing · each found in the filing text

Total revenues · Q3-2025$147M+8% y/y
Revenues before reimbursements · Q3-2025$137M+10% y/y
Net income · Q3-2025$28M+8% y/y
EPS diluted · Q3-2025$0.55+10% y/y
EBITDA · Q3-2025$39M+8% y/y
EBITDA margin · Q3-202528.3%
Cash and cash equivalents · Q3-2025$207M

Guidance

Raising margin guidance

Maintaining revenue guidance, raising margin guidance for full year 2025.

Risks flagged

Q4 2025 faces a 14th-week headwind vs prior year.

“Exponent is returning to a 13-week fiscal fourth quarter in 2025, which poses a headwind for comparisons since Q4 of fiscal 2024 benefited from a 14th week.” · word for word
Read the original on SEC EDGAR ↗

Exponent, Inc. — questions

What did Exponent, Inc. file recently?
10 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-07 — Exponent reported Q2 2026 revenue up 21% YoY to $171.6M, net income up 11% to $29.4M, driven by AI-related user research and strong utilization.

Every figure on this page comes from Exponent, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.